Sales rise 5.22% to Rs 2908.12 crore
Net profit of Glenmark Pharmaceuticals declined 8.43% to Rs 233.99 crore in the quarter ended September 2020 as against Rs 255.54 crore during the previous quarter ended September 2019. Sales rose 5.22% to Rs 2908.12 crore in the quarter ended September 2020 as against Rs 2763.73 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales2908.122763.73 5 OPM %19.0116.30 -PBDT440.30441.46 0 PBT336.24347.30 -3 NP233.99255.54 -8Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
